vs

Side-by-side financial comparison of 4D Molecular Therapeutics, Inc. (FDMT) and System1, Inc. (SST). Click either name above to swap in a different company.

4D Molecular Therapeutics, Inc. is the larger business by last-quarter revenue ($85.1M vs $51.9M, roughly 1.6× System1, Inc.). 4D Molecular Therapeutics, Inc. runs the higher net margin — 22.8% vs -26.0%, a 48.8% gap on every dollar of revenue. On growth, 4D Molecular Therapeutics, Inc. posted the faster year-over-year revenue change (8508900.0% vs -31.3%). Over the past eight quarters, 4D Molecular Therapeutics, Inc.'s revenue compounded faster (5412.6% CAGR vs -21.8%).

4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.

System1 is an American Internet advertising company. Formerly known as OpenMail, it was founded in 2013. It describes itself as operating a "Responsive Acquisition Marketing Platform", and cites privacy as one of its principal foci, although it has been criticized for its influence on privacy-focused properties, including search engine Startpage.com. It is headquartered in Marina del Rey, California.

FDMT vs SST — Head-to-Head

Bigger by revenue
FDMT
FDMT
1.6× larger
FDMT
$85.1M
$51.9M
SST
Growing faster (revenue YoY)
FDMT
FDMT
+8508931.3% gap
FDMT
8508900.0%
-31.3%
SST
Higher net margin
FDMT
FDMT
48.8% more per $
FDMT
22.8%
-26.0%
SST
Faster 2-yr revenue CAGR
FDMT
FDMT
Annualised
FDMT
5412.6%
-21.8%
SST

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
FDMT
FDMT
SST
SST
Revenue
$85.1M
$51.9M
Net Profit
$19.4M
$-13.5M
Gross Margin
41.0%
Operating Margin
17.3%
-33.6%
Net Margin
22.8%
-26.0%
Revenue YoY
8508900.0%
-31.3%
Net Profit YoY
139.1%
4.8%
EPS (diluted)
$0.43
$-3.58

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FDMT
FDMT
SST
SST
Q4 25
$85.1M
$51.9M
Q3 25
$90.0K
$61.6M
Q2 25
$15.0K
$78.1M
Q1 25
$14.0K
$74.5M
Q4 24
$1.0K
$75.6M
Q3 24
$3.0K
$88.8M
Q2 24
$5.0K
$94.6M
Q1 24
$28.0K
$84.9M
Net Profit
FDMT
FDMT
SST
SST
Q4 25
$19.4M
$-13.5M
Q3 25
$-56.9M
$-18.5M
Q2 25
$-54.7M
$-17.5M
Q1 25
$-48.0M
$-15.9M
Q4 24
$-14.2M
Q3 24
$-43.8M
$-23.6M
Q2 24
$-35.0M
$-26.4M
Q1 24
$-32.4M
$-10.5M
Gross Margin
FDMT
FDMT
SST
SST
Q4 25
41.0%
Q3 25
36.9%
Q2 25
35.7%
Q1 25
38.2%
Q4 24
42.1%
Q3 24
28.0%
Q2 24
27.6%
Q1 24
21.9%
Operating Margin
FDMT
FDMT
SST
SST
Q4 25
17.3%
-33.6%
Q3 25
-67983.3%
-25.3%
Q2 25
-396373.3%
-20.4%
Q1 25
-383007.1%
-17.6%
Q4 24
-15.7%
Q3 24
-1704400.0%
-24.6%
Q2 24
-849120.0%
-30.8%
Q1 24
-136200.0%
-30.4%
Net Margin
FDMT
FDMT
SST
SST
Q4 25
22.8%
-26.0%
Q3 25
-63195.6%
-30.1%
Q2 25
-364386.7%
-22.4%
Q1 25
-342657.1%
-21.3%
Q4 24
-18.7%
Q3 24
-1461433.3%
-26.6%
Q2 24
-699060.0%
-27.9%
Q1 24
-115717.9%
-12.4%
EPS (diluted)
FDMT
FDMT
SST
SST
Q4 25
$0.43
$-3.58
Q3 25
$-1.01
$-2.30
Q2 25
$-0.98
$-2.23
Q1 25
$-0.86
$-0.21
Q4 24
$-3.41
Q3 24
$-0.79
$-3.37
Q2 24
$-0.63
$-3.80
Q1 24
$-0.66
$-0.16

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FDMT
FDMT
SST
SST
Cash + ST InvestmentsLiquidity on hand
$402.7M
$86.9M
Total DebtLower is stronger
$305.1M
Stockholders' EquityBook value
$505.7M
$30.5M
Total Assets
$566.7M
$405.0M
Debt / EquityLower = less leverage
10.01×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FDMT
FDMT
SST
SST
Q4 25
$402.7M
$86.9M
Q3 25
$305.1M
$54.6M
Q2 25
$293.2M
$63.6M
Q1 25
$321.4M
$43.9M
Q4 24
$424.9M
$63.6M
Q3 24
$501.9M
$69.1M
Q2 24
$541.9M
$75.7M
Q1 24
$525.9M
$69.9M
Total Debt
FDMT
FDMT
SST
SST
Q4 25
$305.1M
Q3 25
$259.2M
Q2 25
$263.3M
Q1 25
$267.4M
Q4 24
$255.1M
Q3 24
$259.2M
Q2 24
$263.3M
Q1 24
$268.6M
Stockholders' Equity
FDMT
FDMT
SST
SST
Q4 25
$505.7M
$30.5M
Q3 25
$369.0M
$42.7M
Q2 25
$420.9M
$58.2M
Q1 25
$469.7M
$67.2M
Q4 24
$510.6M
$80.3M
Q3 24
$552.9M
$90.3M
Q2 24
$588.3M
$109.4M
Q1 24
$600.6M
$131.7M
Total Assets
FDMT
FDMT
SST
SST
Q4 25
$566.7M
$405.0M
Q3 25
$424.0M
$385.2M
Q2 25
$473.6M
$429.2M
Q1 25
$515.7M
$419.2M
Q4 24
$560.4M
$459.1M
Q3 24
$604.0M
$479.3M
Q2 24
$620.1M
$511.3M
Q1 24
$629.9M
$521.1M
Debt / Equity
FDMT
FDMT
SST
SST
Q4 25
10.01×
Q3 25
6.07×
Q2 25
4.53×
Q1 25
3.98×
Q4 24
3.18×
Q3 24
2.87×
Q2 24
2.41×
Q1 24
2.04×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FDMT
FDMT
SST
SST
Operating Cash FlowLast quarter
$28.6M
$-10.6M
Free Cash FlowOCF − Capex
$28.5M
FCF MarginFCF / Revenue
33.5%
Capex IntensityCapex / Revenue
0.1%
0.0%
Cash ConversionOCF / Net Profit
1.47×
TTM Free Cash FlowTrailing 4 quarters
$-109.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FDMT
FDMT
SST
SST
Q4 25
$28.6M
$-10.6M
Q3 25
$-46.5M
$-2.1M
Q2 25
$-43.4M
$24.5M
Q1 25
$-47.8M
$-15.9M
Q4 24
$-134.6M
$772.0K
Q3 24
$-29.4M
$-5.0K
Q2 24
$-30.2M
$10.0M
Q1 24
$-29.1M
$-16.0M
Free Cash Flow
FDMT
FDMT
SST
SST
Q4 25
$28.5M
Q3 25
$-46.6M
Q2 25
$-43.4M
Q1 25
$-48.4M
$-16.0M
Q4 24
$-138.4M
Q3 24
$-31.2M
$-36.0K
Q2 24
$-30.6M
Q1 24
$-29.8M
FCF Margin
FDMT
FDMT
SST
SST
Q4 25
33.5%
Q3 25
-51765.6%
Q2 25
-289620.0%
Q1 25
-345635.7%
-21.5%
Q4 24
-13837100.0%
Q3 24
-1038966.7%
-0.0%
Q2 24
-611840.0%
Q1 24
-106421.4%
Capex Intensity
FDMT
FDMT
SST
SST
Q4 25
0.1%
0.0%
Q3 25
101.1%
0.0%
Q2 25
440.0%
0.0%
Q1 25
4507.1%
0.1%
Q4 24
378600.0%
0.0%
Q3 24
59266.7%
0.0%
Q2 24
6980.0%
0.0%
Q1 24
2535.7%
0.0%
Cash Conversion
FDMT
FDMT
SST
SST
Q4 25
1.47×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons